Quest Diagnostics’ Self-Collection COVID-19 Test Kit Gets FDA Nod For Emergency Use

Source: Quest Diagnostics

Quest Diagnostics received emergency use authorization for its self-collection COVID-19 test kit from the FDA, according to a FierceHealthcare report.

The company intends more than a half-million test kits to be available by end of June, with plans to make additional kits available on an ongoing basis, the company said Thursday. The news sent Quest’s shares up 3%, Reuters reported.

Quest plans to make the device available through a broad range of healthcare, state, employer and consumer-initiated channels.

Read the full article.

Related Content